FIP1L1-PDGFRα fusion kinase status unknown Chronic eosinophilic leukemia

DrugDrug NameDrug Description
DB00619ImatinibA tyrosine kinase inhibitor used to treat a number of leukemias, myelodysplastic/myeloproliferative disease, systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and gastrointestinal stromal tumors.
DrugDrug NamePhaseStatusCount